Aspira Women's Health INC Form 4 insider transactions

Jack W. Schuler, a director and 10% owner of Aspira Women's Health Inc., reports the acquisition of a Senior Secured Convertible Note due 2030 and changes in beneficial ownership of common stock and warrants.

Interim CEO Sandra Milligan reports the vesting of restricted stock units and subsequent tax withholding, resulting in an adjustment to her holdings of Aspira Women's Health Inc. stock.

Director Jannie Herchuk converted 8,437 restricted stock units into common stock of Aspira Women's Health Inc. on December 31, 2024.

Director Celeste Rachelle Fralick converted 5,000 restricted stock units into common stock, increasing her direct holdings in Aspira Women's Health.

Director Winfred Parnell of Aspira Women's Health Inc. reports the vesting and conversion of restricted stock units into common stock.

Director Stefanie Cavanaugh of Aspira Women's Health Inc. reports the vesting and conversion of restricted stock units into common stock.

Director John Phillip Ragard converted 4,844 restricted stock units into common stock of Aspira Women's Health on December 31, 2024.

Aspira Women's Health Interim CEO Sandra Milligan acquired 20,000 shares of common stock through the vesting of restricted stock units on December 31, 2024.

Director Ellen O'Connor Vos converted vested restricted stock units into 5,312 shares of Aspira Women's Health common stock on December 31, 2024.

Director John Ragard of Aspira Women's Health Inc. reports the vesting and conversion of restricted stock units into common stock, along with a correction to a previous filing.

Aspira Women's Health's Interim CFO, John Kallassy, acquired 25,000 stock options at an exercise price of $0.84 on November 12, 2024.

Aspira Women's Health President, Sandra Milligan, acquired 25,000 stock options at an exercise price of $0.84 on November 12, 2024.

Sandra Milligan, President of Aspira Women's Health Inc., reports the acquisition of 20,000 restricted stock units (RSUs) on October 28, 2024.

Aspira Women's Health CEO, Nicole Sandford, received 25,000 restricted stock units that will vest on December 31, 2024, according to a Form 4 filing.

Director Ellen O'Connor Vos reports the vesting and conversion of restricted stock units into common stock of Aspira Women's Health Inc.

Director Stefanie L. Cavanaugh reports the vesting and conversion of restricted stock units into common stock of Aspira Women's Health Inc.

Director Winfred Parnell reports the vesting and conversion of restricted stock units into common stock of Aspira Women's Health Inc.

Jannie Prestridge Herchuk, a director at Aspira Women's Health Inc., converted 8,438 restricted stock units into common stock on September 30, 2024.

Director John Phillip Ragard converted 4,844 restricted stock units into common stock of Aspira Women's Health Inc. on September 30, 2024.

Celeste Fralick, a director of Aspira Women's Health Inc., converted 5,000 restricted stock units (RSUs) into common stock on September 30, 2024.

Director Ellen Vos reports acquisition of 21,250 restricted stock units in Aspira Women's Health Inc.

Director Winfred Parnell of Aspira Women's Health Inc. reports acquisition of 20,625 restricted stock units on August 22, 2024.

Director John Phillip Ragard acquired 19,375 restricted stock units in Aspira Women's Health Inc.

Interim CFO John Kallassy reports the acquisition of stock options in Aspira Women's Health Inc.

Jannie Herchuk, a director at Aspira Women's Health Inc., was granted 33,750 restricted stock units on August 22, 2024, according to a Form 4 filing.

Celeste Fralick, a director at Aspira Women's Health Inc., was granted 20,000 restricted stock units on August 22, 2024, according to a Form 4 filing.

Director Stefanie Cavanaugh acquired 23,750 restricted stock units in Aspira Women's Health Inc.

Director Celeste Fralick reports acquisition and disposal of Aspira Women's Health Inc. common stock on August 12, 2024, according to a Form 4 filing.

Director Winfred Parnell reported the vesting and acquisition of 15,803 shares of Aspira Women's Health Inc. common stock on August 12, 2024, followed by a disposal of shares.

Director Jannie Herchuk reports acquisition and disposal of Aspira Women's Health Inc. common stock on August 12, 2024.